SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 9,286.51 |
| Enterprise Value ($M) | 9,089.29 |
| Book Value ($M) | 1,970.60 |
| Book Value / Share | 35.29 |
| Price / Book | 4.71 |
| NCAV ($M) | 254.35 |
| NCAV / Share | 4.56 |
| Price / NCAV | 36.51 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.01 |
| Return on Assets (ROA) | 0.01 |
| Return on Equity (ROE) | 0.01 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.24 |
| Current Ratio | 6.35 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,133.02 |
| Assets | 2,849.27 |
| Liabilities | 878.67 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 638.76 |
| Operating Income | 63.30 |
| Net Income | 41.58 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 113.92 |
| Cash from Investing | -123.28 |
| Cash from Financing | 248.96 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Price T Rowe Associates Inc /md/ | 7.20 | -20.86 | |
| 13G/A | Vanguard Group Inc | 9.10 | -2.44 | |
| 13G/A | Eddleman Roy T | 4.85 | 0.00 | |
| 13G/A | BlackRock Inc. | 14.10 | 28.35 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 78,203 | 382,085 | 20.47 | |
| 75,415 | 454,984 | 16.58 | |
| 177,487 | 318,370 | 55.75 | |
| 153,910 | 288,778 | 53.30 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RDUS – Radius Recycling, Inc. | REGN – Regeneron Pharmaceuticals, Inc. |
| REPL – Replimune Group, Inc. | RGNX – REGENXBIO Inc. |
| RIGL – Rigel Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io